NIAID: Recent  Advances in Biomarkers of Allergy and Asthma

1602

NIAID: Recent Advances in Biomarkers of Allergy and Asthma

Friday, February 28, 2014: 2:00 PM-5:00 PM

Convention Center, Upper Level, Room 11AB

2.75 CME/ 3.30 CE

Moderator:

Marshall Plaut , MD FAAAAI

Learning Objectives:

Explain how mediators produced following allergen challenge predict the status of allergic diseases
Describe the relationship of successful allergen immunotherapy to effects on circulating T cell subsets and antibody responses
Appreciate the value of measuring peripheral blood basophil activation in allergic diseases and asthma

2:00 PM

Allergen Challenge as a Biomarker of Disease Severity and of the Effects of Treatment
Stephen R. Durham, MA MD FRCP

2:25 PM

Transcriptomic Changes After Allergen Exposure
Sunil K. Ahuja, MD

2:50 PM

Basophil Activation as a Predictor of Food Allergen Severity
Alexandra F. Santos, MD MSc

3:15 PM

Break

3:30 PM

Basophil Activation as a Biomarker of Food Allergy and Asthma
Wayne G. Shreffler, MD PhD FAAAAI

3:55 PM

T Regulatory Cells as Markers of Allergen Immunotherapy
Andrew D. Luster, MD PhD

4:20 PM

CD27 Effector Cell Depletion During Allergen Immunotherapy
Erik R. Wambre, PhD

Handouts

4:45 PM

Question & Answer

See more of: Course